Anthony J Furlan. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acute DiseaseAnticoagulants/adverse effectsAnticoagulants/therapeutic useClinical Trials, Phase II as Topic/standardsControlled Clinical Trials as Topic/standardsCost-Benefit AnalysisEndpoint DeterminationHumansNeuroprotective Agents/economicsNeuroprotective Agents/therapeutic useResearch DesignRisk AssessmentSample SizeStroke/classificationStroke/drug therapyStroke/prevention & control
Substances: See more » AnticoagulantsNeuroprotective Agents
Year: 2002 PMID: 12052967 DOI: 10.1161/01.str.0000018645.04200.7d
Source DB: PubMed Journal: Stroke ISSN: 0039-2499 Impact factor: 7.914